Molecular cancer phenotype in normal prostate tissue.

Area of Science:

• Oncology
• Molecular Biology
• Genomics

Background:

• Prostate biopsies often lack sensitivity and specificity for accurate cancer detection.
• Early molecular alterations in prostate cancer may precede detectable morphological changes.

Purpose of the Study:

• To identify molecular changes in histologically normal prostate tissue that indicate the presence of prostate cancer.
• To explore novel strategies for clinical management of prostate cancer through early molecular detection.

Main Methods:

• Global microarray screening of 29 tumor-free and 27 cancerous prostate tissues.
• Validation of 29 selected genes using real-time RT-PCR on 114 tumor-free biopsy samples from different risk groups.

Main Results:

• Five genes (FOS, EGR1, MYC, TFRC, FOLH1) showed significant differential expression in morphologically normal prostate tissues across risk groups.
• Gene expression levels were independent of patient age, PSA levels, biopsy history, tissue composition, tumor stage, and grade.
• Transcript levels of these five genes were highly indicative of cancer presence in the prostate.

Conclusions:

• A measurable molecular cancer phenotype exists in histologically normal prostate tissue, signaling cancer elsewhere in the organ.
• These findings suggest potential for new diagnostic approaches in prostate cancer management.
• Further clinical validation in larger cohorts is necessary to establish clinical relevance.